71 related articles for article (PubMed ID: 27179014)
21. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
Yin CM; Yao YF; Yan ZL; Yang HY
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
[No Abstract] [Full Text] [Related]
22. Effects of MDM2 promoter polymorphisms on the development of cervical neoplasia in a Southeastern Brazilian population.
Vargas-Torres SL; Portari EA; Klumb EM; Guillobel HC; Camargo MJ; Russomano FB; Macedo JM
Biomarkers; 2014 Dec; 19(8):637-45. PubMed ID: 25271042
[TBL] [Abstract][Full Text] [Related]
23. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
24. TP53, MDM2, NQO1, and susceptibility to cervical cancer.
Hu X; Zhang Z; Ma D; Huettner PC; Massad LS; Nguyen L; Borecki I; Rader JS
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):755-61. PubMed ID: 20200430
[TBL] [Abstract][Full Text] [Related]
25. A case-control study of methylenetetrahydrofolate reductase polymorphisms in cervical carcinogenesis.
Rao GG; Kurien A; Gossett D; Griffith WF; Coleman RL; Muller CY
Gynecol Oncol; 2006 May; 101(2):250-4. PubMed ID: 16297972
[TBL] [Abstract][Full Text] [Related]
26. Cervical Cancer Genetic Susceptibility: A Systematic Review and Meta-Analyses of Recent Evidence.
Martínez-Nava GA; Fernández-Niño JA; Madrid-Marina V; Torres-Poveda K
PLoS One; 2016; 11(7):e0157344. PubMed ID: 27415837
[TBL] [Abstract][Full Text] [Related]
27. Association between genetic polymorphisms in the promoters of let-7 and risk of cervical squamous cell carcinoma.
Liu J; Ni S
Gene; 2018 Feb; 642():256-260. PubMed ID: 29154871
[TBL] [Abstract][Full Text] [Related]
28. Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma.
Singhal P; Hussain S; Thakur N; Batra S; Salhan S; Bhambani S; Bharadwaj M
DNA Cell Biol; 2013 Jan; 32(1):19-27. PubMed ID: 23210739
[TBL] [Abstract][Full Text] [Related]
29. [Correlation of serum IL-18 level and IL-18 gene promoter polymorphisms to the risk of cervical cancer].
Qi T; Wang Q; Zheng L; Yang HL; Bao J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):754-7. PubMed ID: 18504197
[TBL] [Abstract][Full Text] [Related]
30. [CDH1 polymorphism and its association with the risk of cervical cancer].
Zhou RM; Wang N; Sun DL; Duan YN; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):56-9. PubMed ID: 19563064
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of human nonmetastatic clone 23 type 1 gene and neoplastic lesions of uterine cervix.
Feng CY; Wang PH; Tsai HT; Tee YT; Ko JL; Chen SC; Lin CY; Han CP; Yang JS; Liu YF; Lin LY; Yang SF
Reprod Sci; 2010 Oct; 17(10):886-93. PubMed ID: 20601538
[TBL] [Abstract][Full Text] [Related]
32. Single-Nucleotide Polymorphisms and Haplotypes of Intercellular Adhesion Molecule-1 in Uterine Cervical Carcinogenesis in Taiwanese Women.
Sun YH; Yang SF; Liu YF; Ko JL; Wu CH; Wu TF; Wang PH
Reprod Sci; 2016 Mar; 23(3):401-8. PubMed ID: 26377999
[TBL] [Abstract][Full Text] [Related]
33. Association analysis of rs2275913G>A and rs763780T>C interleukin 17 polymorphisms in Chinese women with cervical cancer.
Sun LX; Wang XB; Huang XJ
Genet Mol Res; 2015 Oct; 14(4):13612-7. PubMed ID: 26535675
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 gene polymorphisms and risk of cervical cancer in a North Indian population.
Pandey S; Mittal RD; Srivastava M; Srivastava K; Mittal B
Int J Gynecol Cancer; 2010 May; 20(4):625-30. PubMed ID: 20686383
[TBL] [Abstract][Full Text] [Related]
35. Genetic Predisposition to Cervical Cancer and the Association With XRCC1 and TGFB1 Polymorphisms.
Al-Harbi NM; Bin Judia SS; Mishra KN; Shoukri MM; Alsbeih GA
Int J Gynecol Cancer; 2017 Nov; 27(9):1949-1956. PubMed ID: 28906311
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-inducible factor 1α polymorphisms and early-stage cervical cancer.
Kim YH; Park IA; Park WY; Kim JW; Kim SC; Park NH; Song YS; Kang SB
Int J Gynecol Cancer; 2011 Jan; 21(1):2-7. PubMed ID: 21330825
[TBL] [Abstract][Full Text] [Related]
37. Association Between the IL-6 rs1800795 Polymorphism and the Risk of Cervical Cancer: A Meta-Analysis of 1210 Cases and 1525 Controls.
Liu H; Lyu D; Zhang Y; Sheng L; Tang N
Technol Cancer Res Treat; 2017 Oct; 16(5):662-667. PubMed ID: 27777338
[TBL] [Abstract][Full Text] [Related]
38. Association between six genetic variants of IL-17A and IL-17F and cervical cancer risk: a case-control study.
Lv Q; Zhu D; Zhang J; Yi Y; Yang S; Zhang W
Tumour Biol; 2015 May; 36(5):3979-84. PubMed ID: 25596084
[TBL] [Abstract][Full Text] [Related]
39. Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.
Chen D; Gyllensten U
Carcinogenesis; 2014 Aug; 35(8):1765-9. PubMed ID: 24743517
[TBL] [Abstract][Full Text] [Related]
40. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
